🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple myeloma (MM) is a neoplastic disease deriving from an abnormal pro...
Status
Active Not Recruiting
Location
Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Start Date
2019-01-03
Trial ID
NCT03829371
Treatments Being Tested
The study is designed as a randomized, controlled, open-label, assessor bli...
Status
Active Not Recruiting
Location
Complejo Hospitalario Universitario A Coruña
Start Date
2018-10-22
Trial ID
NCT03742297
Treatments Being Tested
This is a multicenter, randomized, blinded, 2-arm phase IIb trial that will...
Status
Terminated
Location
Charité - Campus Benjamin Franklin Medizinische Klinik II
Start Date
2013-08
Trial ID
NCT02145598
Treatments Being Tested
The primary objective is to analyze and compare the efficacy, the response ...
Status
Completed
Location
Hospital Royo Villanova
Start Date
2005-03
Trial ID
NCT00443235
Treatments Being Tested
This is a prospective, observational, single group and multicenter study to...
Status
Unknown
Location
Hospital Universitario Del Sureste
Start Date
2021-11-30
Trial ID
NCT05218603
Treatments Being Tested
Study phase: phase III Study objective: * Comparison of Bortezomib, Melph...
Status
Completed
Location
AU-Brisbane-PAH
Start Date
2011-01
Trial ID
NCT01208766
The 3-drug therapy of Bortezomib-Melphalan-Prednisolone (VMP) is a standard...
Status
Completed
Location
Soonchunhyang University Bucheon hospital
Start Date
2018-11-15
Trial ID
NCT04151615
The purpose of this study is to determine if the addition of daratumumab to...
Status
Completed
Location
Beijing Chaoyang Hospital
Start Date
2017-11-23
Trial ID
NCT03217812
Treatments Being Tested
The purpose of this study is to assess the 2-year progression-free survival...
Status
Completed
Location
Multiple Locations
Start Date
2011-05
Trial ID
NCT02474563
Treatments Being Tested
The purpose of this study is to evaluate the clinical benefit of subcutaneo...
Status
Completed
Location
Cancer Center of Central Connecticut - Southington
Start Date
2018-04-26
Trial ID
NCT03412565
Treatments Being Tested